Table 1. Immunophenotypes and associated mutations in patients with MCD.
Patient number |
Reactivity to KS antibody in |
Serum AgKS (ng/ml) | Type of mutation | Mutation | MCD type | |
---|---|---|---|---|---|---|
Stroma | Keratocytes | |||||
1 |
-ve |
-ve |
<4 |
Frameshift |
p.Ser32GlnfsX36 |
I |
2 |
-ve |
-ve |
<2 |
Missense |
p.Gly52Asp |
I |
3 |
-ve |
-ve |
Not done |
Missense |
Ser53Leu |
I |
4 |
-ve |
-ve |
<4 |
Missense |
p.Phe107Ser |
I |
5 |
-ve |
-ve |
<4 |
Missense |
p.Phe107Ser |
I |
6 |
-ve |
-ve |
Not done |
Nonsense |
p.Trp123X |
I |
7 |
-ve |
-ve |
<4 |
Nonsense |
p.Cys153X |
I |
8# |
-ve |
-ve |
<2 |
Insertion |
p.Arg195–196ins |
I |
9 |
-ve |
-ve |
<4 |
Missense |
p.Pro204Gln |
I |
10# |
-ve |
-ve |
<2 |
Frameshift |
p.Arg205TrpfsX176 |
I |
11 |
-ve |
-ve |
6 |
Insertion |
p.Trp219–220ins |
I |
12 |
-ve |
-ve |
<4 |
Insertion |
p.Trp219–220ins |
I |
13 |
-ve |
-ve |
<4 |
Insertion |
p.Trp219–220ins |
I |
14 |
-ve |
-ve |
<4 |
Nonsense |
p.Glu347X |
I |
15 |
-ve |
-ve |
5 |
Frameshift |
p.Val6ProfsX55 |
I |
16 |
-ve |
-ve |
6 |
Missense |
p.Ser54Phe |
I |
17 |
-ve |
-ve |
7 |
Frameshift |
p.Phe60LeufsX10 |
I |
18 |
-ve |
-ve |
8 |
Frameshift |
p.Phe60LeufsX10 |
I |
19 |
-ve |
-ve |
Not done |
Missense |
Cys165Ser |
I |
20 |
-ve |
-ve |
Not done |
Missense |
Cys165Trp |
I |
21A |
-ve |
-ve |
<2 |
Missense |
p.Pro204Arg |
I |
22A |
Not done |
Not done |
<2 |
Missense |
p.Pro204Arg |
I |
23 |
-ve |
-ve |
<2 |
Insertion |
p.Trp219–220ins |
I |
24 |
-ve |
-ve |
Not done |
Insertion |
p.Trp219–220ins |
I |
25 |
-ve |
-ve |
<2 |
Missense |
p.Asp221Tyr |
I |
26 |
-ve |
-ve |
Not done |
Missense |
p.Arg334Cys |
I |
27 |
-ve |
-ve |
Not done |
Frameshift |
p.His335CysfsX27 |
I |
28B |
-ve |
-ve |
<4 |
Frameshift |
p.His335CysfsX27 |
I |
29B |
-ve |
-ve |
<2 |
Frameshift |
p.His335CysfsX27 |
I |
30B |
Not done |
Not done |
<2 |
Frameshift |
p.His335CysfsX27 |
I |
31B |
Not done |
Not done |
<2 |
Frameshift |
p.His335CysfsX27 |
I |
32C |
-ve |
+ve |
<4 |
Missense |
p.[Ser98Trp]+[Phe107Ser] |
IA |
33C |
-ve |
+ve |
<4 |
Missense |
p.[Ser98Trp]+[Phe107Ser] |
IA |
34 |
-ve |
+ve |
<4 |
Missense |
p.Phe121Ser |
IA |
35 |
-ve |
+ve |
<4 |
Insertion |
p.Trp219–220ins |
IA |
36 |
-ve |
+ve |
Not done |
Missense |
p.Asp221Glu |
IA |
37#D |
-ve |
+ve |
Not done |
Missense |
p.Asp221Glu |
IA |
38#D |
-ve |
+ve |
Not done |
Missense |
p.Asp221Glu |
IA |
39 |
+ve |
+ve |
not done |
Frameshift |
p.[Phe67SerfsX3]+[=] |
II |
40 |
+ve |
+ve |
not done |
Nonsense +missense |
p.[Trp2X;Leu3Met]+ [Trp2X;Leu3Met] |
II |
41E |
Not done |
Not done |
105 |
- |
No CHST6 mutation |
II? |
42E |
Not done |
Not done |
42 |
- |
No CHST6 mutation |
II/atypical? |
43 |
Not done |
Not done |
<4 |
Missense |
p.Gly52Asp |
I/IA |
44 |
Not done |
Not done |
<4 |
Frameshift |
p.Phe60LeufsX10 |
I/IA |
45 |
Not done |
Not done |
<4 |
Nonsense |
p.Gly309X |
I/IA |
46 |
Not done |
Not done |
<4 |
Missense |
p.[Val56Arg]+ [Ser167Phe] |
I/IA |
47 |
Not done |
Not done |
<4 |
Missense |
p.Ala73Thr |
I/IA |
48 |
Not done |
Not done |
8 |
Nonsense |
p.Trp123X |
I/IA |
49 |
Not done |
Not done |
<4 |
Missense |
p.Ser131Pro |
I/IA |
50F |
Not done |
Not done |
<4 |
Frameshift+ Missense |
[Gln182ArgfsX199]+ [Leu276Pro] |
I/IA |
51F |
Not done |
Not done |
<4 |
Missense |
p.Leu276Pro |
I/IA |
52 |
Not done |
Not done |
<2 |
Missense |
p.Leu193Pro |
I/IA |
53 |
Not done |
Not done |
<2 |
Missense |
p.Arg272Ser |
I/IA |
54 |
-ve |
-ve |
63 |
Nonsense |
p.Gln18X |
Atypical |
55 |
-ve |
+ve |
95 |
Missense |
p.Asp221Glu |
Atypical |
56 |
-ve |
+ve |
388 |
Missense |
p.[Ser98Leu]+[=] |
Atypical |
57 |
-ve |
-ve |
33 |
Missense |
p.Phe178Cys |
Atypical |
58 |
-ve |
-ve |
19 |
Missense |
p.Arg202Ser |
Atypical |
59 |
-ve |
+ve |
142 |
Missense |
p.Asp221Glu |
Atypical |
60G |
-ve |
-ve |
61 |
Missense |
p.[Ser210Phe]+[Asp221Glu] |
Atypical |
61G |
-ve |
+ve |
Not done |
Missense |
p.[Ser210Phe]+[Asp221Glu] |
IA? |
62H |
+ve |
+ve |
101 |
Missense |
Asp221Tyr |
II |
63H |
-ve |
+ve |
<4 |
Missense |
Asp221Tyr |
IA |
64H | -ve | -ve | 6 | Missense | Asp221Tyr | I |
Details of serum and corneal AgKS reactivity, associated CHST6 mutations and corresponding MCD immunophenotypes are listed for all patients studied. Reactivity to AgKS in cornea is denoted as present (+ve) or absent (-ve). Mutations in the protein are as described earlier [16,17]. Members of the same family are denoted by letters A-H in superscripts. The sharp (hash mark ‘#’) indicates patients that had both corneas evaluated.